Callan JMB Inc. Common Stock Total Liabilities
Callan JMB Inc. Common Stock total liabilities. Based on the latest financial reports, Callan JMB Inc. Common Stock (CJMB) has total liabilities worth $3.77 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Callan JMB Inc. Common Stock liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Callan JMB Inc. Common Stock (2022–2025)
Total liabilities of Callan JMB Inc. Common Stock from 2022 to 2025. This chart illustrates how Callan JMB Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Callan JMB Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Callan JMB Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Diaceutics PLC
LSE:DXRX
|
UK | GBX9.53 Million |
|
MPAY S.A. ZY-50
F:8NJ
|
Germany | €31.87 Million |
|
707 Cayman Holdings Limited Ordinary Shares
NASDAQ:JEM
|
USA | $25.95 Million |
|
Alliance Mining Corp
V:ALM
|
Canada | CA$3.73 Million |
|
Chatham Rock Phosphate Ltd
V:NZP
|
Canada | CA$525.38K |
|
Agereh Technologies Inc
V:AUTO
|
Canada | CA$6.35 Million |
|
Frontier Developments Plc
LSE:FDEV
|
UK | GBX42.42 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Callan JMB Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Callan JMB Inc. Common Stock balance sheet assets.
Liquidity & Leverage Metrics
Callan JMB Inc. Common Stock Total Liabilities Ratios Explained
Callan JMB Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.30 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.53 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.85 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Callan JMB Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Callan JMB Inc. Common Stock (2022–2025)
The table below shows the annual total liabilities of Callan JMB Inc. Common Stock from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $3.45 Million | +80.58% |
| 2024-12-31 | $1.91 Million | +109.74% |
| 2023-12-31 | $910.27K | -26.56% |
| 2022-12-31 | $1.24 Million | -- |
About Callan JMB Inc. Common Stock
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryo… Read more